US-based Olympus Biotech has launched a contract manufacturing organisation (CMO) operation to complement its current focus on regenerative medicines. The …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

